Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome

Borisova A.B.; Veltishchev D.Yu.; Lisitsyna T.A.; Reshetnyak T.M.; Seravina O.F.; Kovalevskaya O.B.; Cheldieva F.A.; Abramkin A.A.

doi:https://doi.org/10.17116/jnevro202212203165

Borisova A.B.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»;
Nasonova Research Institute of Rheumatology

Veltishchev D.Yu.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»;
Pirogov Russian National Research Medical University

Lisitsyna T.A.

Nasonova Research Institute of Rheumatology

Reshetnyak T.M.

Nasonova Research Institute of Rheumatology;
Russian Medical Academy of Continuing Professional Education

Seravina O.F.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»

Kovalevskaya O.B.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»

Cheldieva F.A.

Nasonova Research Institute of Rheumatology;
Russian Medical Academy of Continuing Professional Education

Abramkin A.A.

Nasonova Research Institute of Rheumatology

Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome

Authors:

Borisova A.B., Veltishchev D.Yu., Lisitsyna T.A., Reshetnyak T.M., Seravina O.F., Kovalevskaya O.B., Cheldieva F.A., Abramkin A.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(3): 65‑71

DOI: 10.17116/jnevro202212203165

Read: 4203 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Borisova AB, Veltishchev DYu, Lisitsyna TA, et al. . Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(3):65‑71. (In Russ.)
https://doi.org/10.17116/jnevro202212203165

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

The aim of this work was to analyze the frequency and, spectrum of mental disorders (MD), and stressful factors, as well as the characteristics of anxiety and depressive spectrum disorders (ADSD) in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).

MATERIAL AND METHODS

The study included 155 patients (37 (23.9%) men and 118 (76.1%) women) aged 18 to 69 years ((M±SD) 37.7±12.3 years), including. 61 (39.3%) patients — with a reliable diagnosis of SLE according to the 2019 EULAR/ACR criteria, 48 (30.9%) patients with — SLE with secondary APS and 46 (29.7%) — with primary APS (PAPS), established according to the international criteria of 2006.

RESULTS

The majority of the examined patients were found to hadve MD (current MD in 145 (93.5%) patients). ADSD prevailed in all groups: in 58 (95.1%) patients with SLE, in 42 (87.5%) — with SLE with APS and in, 39 (84.8%) — with APS. Patients with SLE were exposed to stressful events in childhood (predominantly parental deprivation) more often than patients with SLE with APS and PAPS were exposed to stressful events in childhood (93.4% versus 81.2% and 69.6%, respectively; predominantly parental deprivation). ADSD in these patients developed mainly in pre-adolescence, with a tendency towards chronic variants without remission, which leads to a greater vulnerability of the patients in this group to stressful events compared with patients with APS (p=0.05).

CONCLUSION

When diagnosing and treating MD in patients with SLE and APS, special attention should be paid to the analysis of the history of stressful eventsstress history of patients, which affects the formation of common predisposing and provoking factors, both MD and RD, aggravating their course and prognosis.

Keywords:

system lupus erythematosus

antiphospholipid syndrome

depression

anxiety

stress

Authors:

Borisova A.B.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»;
Nasonova Research Institute of Rheumatology

Veltishchev D.Yu.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»;
Pirogov Russian National Research Medical University

Lisitsyna T.A.

Nasonova Research Institute of Rheumatology

Reshetnyak T.M.

Nasonova Research Institute of Rheumatology;
Russian Medical Academy of Continuing Professional Education

Seravina O.F.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»

Kovalevskaya O.B.

Moscow Research Institute of Psychiatry — Branch «Serbsky National Medical Research Center of Psychiatry and Narcology»

Cheldieva F.A.

Nasonova Research Institute of Rheumatology;
Russian Medical Academy of Continuing Professional Education

Abramkin A.A.

Nasonova Research Institute of Rheumatology

Received:

23.11.2021

Accepted:

30.11.2021

Close metadata

References:

Lisitsyna TA, Veltishchev DYu, Seravina OF, Kovalevskaya OB, Starovoytova MN, Desinova OV, Abramkin AA, Ovcharov PS, Vasil’ev VI, Alekberova ZS, Krasnov VN, Nasonov EL. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases. Terarkch. 2018. (In Russ.). https://doi.org/10.26442/terarkh201890530-37
Gris JC, Cyprien F, Bouvier S, et al. Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study. World Journal of Biological Psychiatry. 2017;0(0). https://doi.org/10.1080/15622975.2017.1333146
Rodrigues CEM, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. European Journal of Clinical Investigation. 2010; 40(4):350–359. https://doi.org/10.1111/j.1365-2362.2010.02263.x
Lisitsyna TA, Veltishchev DY, Nasonov EL. Stressors and depressive disorders in rheumatic diseases. Nauchno-Prakticheskaja Revmatologija. 2013;51(2):98-103. (In Russ.). https://doi.org/10.14412/1995-4484-2013-634
Grygiel-Górniak B, Limphaibool N, Puszczewicz M. Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry and Clinical Neurosciences. 2019;73(6): 302–316. https://doi.org/10.1111/pcn.12826
Chapman DP, Whitfield CL, Felitti VJ, et al. Adverse childhood experiences and the risk of depressive disorders in adulthood. Journal of Affective Disorders. 2004;82(2):217-225. https://doi.org/10.1016/j.jad.2003.12.013
Dube SR, Fairweather D, Pearson WS, et al. Cumulative childhood stress and autoimmune diseases in adults. Psychosomatic Medicine. 2009. https://doi.org/10.1097/PSY.0b013e3181907888
Rampton DS. The influence of stress on the development and severity of immune-mediated diseases. Journal of Rheumatology. 2011;38(suppl 88):43-47. https://doi.org/10.3899/jrheum.110904
Zgraggen L, Fischer JE, Mischler K, et al. Relationship between hemoconcentration and blood coagulation responses to acute mental stress. Thrombosis Research. 2005;115(3). https://doi.org/10.1016/j.thromres.2004.08.022
Bentur OS, Sarig G, Brenner B, et al. Effects of Acute Stress on Thrombosis. Seminars in Thrombosis and Hemostasis. 2018;44(7):662-668. https://doi.org/10.1055/s-0038-1660853
Austin AW, Wissmann T, Von Kanel R. Stress and hemostasis: An update. Seminars in Thrombosis and Hemostasis. 2013;39(8). https://doi.org/10.1055/s-0033-1357487
Von Känel R. Acute mental stress and hemostasis: When physiology becomes vascular harm. Thrombosis Research. 2015;135(S1):52-55. https://doi.org/10.1016/S0049-3848(15)50444-1
Zhdanov RI, Kupriyanov RV, Zhdanova SI, et al. Relationship Between Haemostasis Parameters and Anxiety Under Examination Stress: A Pilot Study. Indian Journal of Hematology and Blood Transfusion. 2018;34(4):727-730. https://doi.org/10.1007/s12288-018-0980-7
Petri M, Orbai AM, Alarcõn GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism. 2012;64(8). https://doi.org/10.1002/art.34473
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis. 2006. https://doi.org/10.1111/j.1538-7836.2006.01753.x
Castrejón I, Rúa-Figueroa I, Rosario MP, et al. Clinical Composite Measures of Disease Activity and Damage Used to Evaluate Patients With Systemic Lupus Erythematosus: A Systematic Literature Review. Reumatología Clínica (English Edition). 2014;10(5). https://doi.org/10.1016/j.reumae.2014.01.011
Krupp LB, Larocca NG, Muir Nash J, et al. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology. 1989. https://doi.org/10.1001/archneur.1989.00520460115022
Handa M, McKown S, Gawlicki M. PSY39 linguistic validation of the lupus qol questionnaire into 13 languages. Value in Health. 2009;12(3). https://doi.org/10.1016/s1098-3015(10)73749-9
Feng YS, Kohlmann T, Janssen MF, et al. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Quality of Life Research. 2020. https://doi.org/10.1007/s11136-020-02688-y
Fazekas C, Linder D, Matzer F, et al. Development of a visual tool to assess six dimensions of health and its validation in patients with endocrine disorders. Wiener Klinische Wochenschrift. 2021. https://doi.org/10.1007/s00508-021-01809-y
Kakorina EP, Maksimova MV, Mishnev OD. The use of the International Statistical Classification of Diseases and Problems Related to Health, the tenth revision (ICD-10) in the practice of domestic medicine. 2012. Methodological guide (In Russ.).
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979. https://doi.org/10.1192/bjp.134.4.382
Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
Luria AP. Higher cortical functions of a person. Book on Demand. 2012. (In Russ.).
Rubinstein SYa. Experimental methods of pathopsychology and experience of their application in the clinic. EKSMO-Press; 1999. (In Russ.).
Kherson BG. Method of pictograms in psychodiagnostics of mental diseases. Speech; 2003. (In Russ.).
Dragunskaya LS. Study of signs of depressive states using the «Pictogram» method. Experimental Studies in Pathopsychology. 1976. (In Russ.).
Loginova SV, Rubinstein SYa. On the application of the «pictogram» method for the experimental study of the thinking of mental patients. 1972. (In Russ.).
Zeigarnik BV. Narusheniya myshleniya u psikhicheski bol’nykh. 1958. (In Russ.).
Zeigarnik BV. Patologiya myshleniya. 1962. (In Russ.).
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior. 1983. https://doi.org/10.2307/2136404
Lisicyna TA, Vel’tishchev DYu, Seravina OF, Kovalevskaya OB, Drozhdina EN, Zeltyn’ AE, Marchenko AS, Shelomkova OA. Rekomendacii po diagnostike i lecheniyu psihicheskih rasstrojstv pri revmaticheskih zabo-levaniyah. Rossijskie klinicheskie rekomendacii. Revmatologiya. Pod red. akad. RAN Nasonova E.L. GEOTAR-Media; 2017;411-434. (In Russ.).
Gris JC, Nobile B, Bouvier S. Neuropsychiatric presentations of antiphospholipid antibodies. Thrombosis Research. 2015;135(S1):56-59. https://doi.org/10.1016/S0049-3848(15)50445-3
Andersson NW, Gustafsson LN, Okkels N, et al. Depression and the risk of autoimmune disease: A nationally representative, prospective longitudinal study. Psychological Medicine. 2015;45(16). https://doi.org/10.1017/S0033291715001488
Marrie RA, Walld R, Bolton JM, et al. Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease. Epidemiology and Psychiatric Sciences. 2019;28(3). https://doi.org/10.1017/S2045796017000579
Stojanovich L. Stress and Autoimmunity. Autoimmun Rev. 2010. https://doi.org/10.1016/j.autrev.2009.11.014
Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin. 2014;140(3):774-815. https://doi.org/10.1037/a0035302
Roberts AL, Malspeis S, Hospital W, et al. Association of trauma and posttraumatic stress disorder with incident systemic lupus erythematosus (SLE) in a longitudinal cohort of women. Arthritis Rheumatol. 2018;69(11):2162-2169. Association. https://doi.org/10.1002/art.40222
Drozhdina EN, Kovalevskaya OB, Seravina OF, Shelepina TA, Lisitsina TA, Kouzmina NN, Veltishchev DYu. The Role of Traumatic Factors in Maladjustment of Children and Adolescents With Juvenile Arthritis. 2012;22:23-25. (In Russ.).